Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion type Assertion NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_head.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion description "[GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_provenance.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion evidence source_evidence_literature NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_provenance.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion SIO_000772 18556336 NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_provenance.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion wasDerivedFrom befree-20150227 NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_provenance.
- NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_assertion wasGeneratedBy ECO_0000203 NP861583.RA0kGisN8-5rNGicGp-kfkZUI2SUgawalWiuzg7g3Qfl0130_provenance.